A detailed history of Canopy Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Canopy Partners, LLC holds 34,588 shares of PFE stock, worth $869,196. This represents 0.43% of its overall portfolio holdings.

Number of Shares
34,588
Previous 32,970 4.91%
Holding current value
$869,196
Previous $923 Million 8.51%
% of portfolio
0.43%
Previous 0.43%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$27.7 - $31.39 $44,818 - $50,789
1,618 Added 4.91%
34,588 $1 Billion
Q2 2024

Aug 09, 2024

BUY
$25.26 - $29.6 $176,239 - $206,519
6,977 Added 26.84%
32,970 $923 Million
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $70,472 - $80,925
2,722 Added 11.7%
25,993 $721 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $608,071 - $789,817
23,271 New
23,271 $670 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $141B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Canopy Partners, LLC Portfolio

Follow Canopy Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canopy Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Canopy Partners, LLC with notifications on news.